Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALINA ALLEN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1467636902
CMS profile
690039
Location
ROCHESTER, MN

General Payments · PY2020–2024

$172,789.20

  • Reported across 96 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$81,506.03

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $42,642.78 17
Madrigal Pharmaceuticals $18,654.20 14
Boehringer Ingelheim Pharmaceuticals, Inc. $12,698.88 11
GlaxoSmithKline, LLC. $3,824.30 8
Boehringer Ingelheim International GmbH $3,685.87 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $2,000.00 1
PY2021 $20,852.02 6
PY2022 $38,063.35 13
PY2023 $30,367.80 23
PY2024 $81,506.03 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim International GmbH $1,113.87 04/23/2024 Consulting Fee Undisputed 01/23/2026 1118021910 CMS
Boehringer Ingelheim International GmbH $1,470.00 04/24/2024 Consulting Fee Undisputed 01/23/2026 1118021912 CMS
Boehringer Ingelheim International GmbH $1,102.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1118021908 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $933.08 04/30/2024 Travel and Lodging Undisputed 01/23/2026 1118021906 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118021888 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.30 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118021890 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.30 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118021892 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $38.12 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118021896 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $190.87 05/07/2024 Travel and Lodging Undisputed 01/23/2026 1118021904 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $162.29 05/10/2024 Travel and Lodging Undisputed 01/23/2026 1118021902 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $77.36 05/13/2024 Travel and Lodging Undisputed 01/23/2026 1118021898 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 07/09/2024 Food and Beverage Undisputed 01/23/2026 1118021894 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 07/09/2024 Travel and Lodging Undisputed 01/23/2026 1118021900 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11,025.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 1118021914 CMS
GlaxoSmithKline, LLC. $363.72 04/06/2024 Travel and Lodging Undisputed 01/23/2026 1116452769 CMS
GlaxoSmithKline, LLC. $34.44 04/07/2024 Food and Beverage Undisputed 01/23/2026 1116081784 CMS
GlaxoSmithKline, LLC. $29.35 04/07/2024 Food and Beverage Undisputed 01/23/2026 1116140630 CMS
GlaxoSmithKline, LLC. $66.59 04/07/2024 Food and Beverage Undisputed 01/23/2026 1116240482 CMS
GlaxoSmithKline, LLC. $59.70 04/07/2024 Food and Beverage Undisputed 01/23/2026 1116491811 CMS
GlaxoSmithKline, LLC. $62.50 05/13/2024 Travel and Lodging Undisputed 01/23/2026 1115951673 CMS
GlaxoSmithKline, LLC. $8.00 05/13/2024 Food and Beverage Undisputed 01/23/2026 1116281180 CMS
GlaxoSmithKline, LLC. $3,200.00 05/23/2024 Consulting Fee Undisputed 01/23/2026 1116107296 CMS
Madrigal Pharmaceuticals $343.96 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144160105 CMS
Madrigal Pharmaceuticals $77.39 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144160107 CMS
Madrigal Pharmaceuticals $80.91 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144160109 CMS
Madrigal Pharmaceuticals $8,000.00 09/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144160111 CMS
Madrigal Pharmaceuticals $226.86 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144160113 CMS
Madrigal Pharmaceuticals $94.62 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144160115 CMS
Madrigal Pharmaceuticals $254.00 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144160117 CMS
Madrigal Pharmaceuticals $109.31 10/19/2024 Food and Beverage Undisputed 01/23/2026 1144160119 CMS
Madrigal Pharmaceuticals $5,200.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144160121 CMS
Madrigal Pharmaceuticals $78.27 11/14/2024 Food and Beverage Undisputed 01/23/2026 1144160123 CMS
Madrigal Pharmaceuticals $42.53 11/14/2024 Food and Beverage Undisputed 01/23/2026 1144160125 CMS
Madrigal Pharmaceuticals $1,600.00 11/14/2024 Honoraria Undisputed 01/23/2026 1144160127 CMS
Madrigal Pharmaceuticals $146.35 11/19/2024 Food and Beverage Undisputed 01/23/2026 1144160129 CMS
Madrigal Pharmaceuticals $2,400.00 12/05/2024 Honoraria Undisputed 01/23/2026 1144160131 CMS
Novo Nordisk Inc $2,227.50 04/08/2024 Consulting Fee Undisputed 01/23/2026 1096742580 CMS
Novo Nordisk Inc $2,227.50 04/08/2024 Consulting Fee Undisputed 01/23/2026 1097496680 CMS
Novo Nordisk Inc $387.50 04/14/2024 Consulting Fee Undisputed 01/23/2026 1096742379 CMS
Novo Nordisk Inc $11,431.25 04/15/2024 Consulting Fee Undisputed 01/23/2026 1096771410 CMS
Novo Nordisk Inc $1,055.76 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1096947544 CMS
Novo Nordisk Inc $303.67 04/15/2024 Food and Beverage Undisputed 01/23/2026 1097010002 CMS
Novo Nordisk Inc $409.20 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1097322886 CMS
Novo Nordisk Inc $180.00 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1097493908 CMS
Novo Nordisk Inc $3,564.00 04/29/2024 Consulting Fee Undisputed 01/23/2026 1097838948 CMS
Novo Nordisk Inc $3,564.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1097838922 CMS
Novo Nordisk Inc $775.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 1096715217 CMS
Novo Nordisk Inc $11,431.25 09/19/2024 Consulting Fee Undisputed 01/23/2026 1097322448 CMS
Novo Nordisk Inc $173.85 09/19/2024 Food and Beverage Undisputed 01/23/2026 1097460802 CMS
Novo Nordisk Inc $222.29 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1097609053 CMS
Novo Nordisk Inc $758.38 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1097695639 CMS
Novo Nordisk Inc $831.63 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1097832829 CMS
Novo Nordisk Inc $3,100.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1096879467 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.